Dr. Reddy's Laboratories Ltd.

₹1287.4

Dr. Reddy's Laboratories Ltd.

Add Alert
Add Watchlist

₹1287.4

₹1287.4

9.5 (0.74%) - 28 Jul 2025 04:29 PM

About Company

Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Market Cap. ₹ 107,444 Cr.
52 Week - High/Low ₹ 1,421/1,020
P/E Ratio 15.47
P/B Ratio 3.70
Enterprise Value ₹ 106,457 Cr.
ROE % 20.25
RSI Value 50.89
EMA 50 1267.71
EMA 200 1245.21
Market Cap. ₹ 107,444 Cr.
52 Week - High/Low ₹ 1,421/1,020
P/E Ratio 18.77
P/B Ratio 3.18
Enterprise Value ₹ 104,824 Cr.
ROE % 18.61
RSI Value 50.89
EMA 50 1267.71
EMA 200 1245.21

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.